BRAF/MEK抑制剂治疗转移性黑色素瘤后出现的肉芽肿性间质性肾炎。 - Suppr

Suppr

超能文献

Granulomatous interstitial nephritis following BRAF/MEK inhibitor treatment for metastatic melanoma.

作者信息

Garo Florian, Reboul Pascal, Gerbal Marion, Moranne Olivier

机构信息

Nephrology, Dialysis, Apheresis Unit, Centre Hospitalier Universitaire de Nîmes, Nîmes, France.

Department of Pathology, Centre Hospitalier Universitaire de Nîmes, Nîmes, France.

出版信息

J Nephrol. 2023 Dec;36(9):2649-2650. doi: 10.1007/s40620-023-01736-3. Epub 2023 Aug 14.

DOI:10.1007/s40620-023-01736-3

PMID:37578595

Abstract

摘要

相似文献

Granulomatous interstitial nephritis following BRAF/MEK inhibitor treatment for metastatic melanoma.BRAF/MEK抑制剂治疗转移性黑色素瘤后出现的肉芽肿性间质性肾炎。

J Nephrol. 2023 Dec;36(9):2649-2650. doi: 10.1007/s40620-023-01736-3. Epub 2023 Aug 14.

Truth or dare: switching BRAF/MEK inhibitors after acute interstitial nephritis in a patient with metastatic melanoma - A case report and review of the literature.真心话大冒险：在转移性黑色素瘤患者发生急性间质性肾炎后切换 BRAF/MEK 抑制剂——病例报告及文献复习。

Acta Clin Belg. 2023 Jun;78(3):215-222. doi: 10.1080/17843286.2022.2114684. Epub 2022 Aug 23.

Granulomatous nephritis and dermatitis in a patient with BRAF V600E mutant metastatic melanoma treated with dabrafenib and trametinib.一名BRAF V600E突变转移性黑色素瘤患者接受达拉非尼和曲美替尼治疗后出现肉芽肿性肾炎和皮炎。

Melanoma Res. 2015 Dec;25(6):550-4. doi: 10.1097/CMR.0000000000000186.

Acute granulomatous interstitial nephritis in a patient with metastatic melanoma on targeted therapy with dabrafenib and trametinib-A case report.靶向治疗下伴转移性黑色素瘤的患者出现急性粒细胞性间质性肾炎-1 例报告。

Cancer Rep (Hoboken). 2022 Jul;5(7):e1520. doi: 10.1002/cnr2.1520. Epub 2021 Aug 5.

Dabrafenib- and trametinib-associated glomerular toxicity: A case report.达布拉非尼和曲美替尼相关的肾小球毒性：一例报告。

Medicine (Baltimore). 2022 Jan 7;101(1):e28485. doi: 10.1097/MD.0000000000028485.

Combined BRAF and MEK inhibition for the treatment of BRAF-mutated metastatic melanoma.联合 BRAF 和 MEK 抑制治疗 BRAF 突变转移性黑色素瘤。

Cancer Treat Rev. 2015 Jun;41(6):519-26. doi: 10.1016/j.ctrv.2015.04.010. Epub 2015 Apr 29.

[BRAF inhibitor and MEK inhibitor].[BRAF抑制剂和MEK抑制剂]

Gan To Kagaku Ryoho. 2015 Apr;42(4):428-33.

Targeted Therapy for Melanoma.黑色素瘤的靶向治疗

Cancer Treat Res. 2016;167:251-62. doi: 10.1007/978-3-319-22539-5_10.

Efficacy and tolerance of BRAF and MEK inhibitors on metastatic melanoma carrying the orphan pV600_K601 delinsE mutation of the BRAF gene.

Int J Dermatol. 2021 Jul;60(7):e283-e284. doi: 10.1111/ijd.15538. Epub 2021 Mar 18.

TORC1 suppression predicts responsiveness to RAF and MEK inhibition in BRAF-mutant melanoma.TORC1 抑制预测 RAF 和 MEK 抑制对 BRAF 突变型黑色素瘤的反应性。

Sci Transl Med. 2013 Jul 31;5(196):196ra98. doi: 10.1126/scitranslmed.3005753.

引用本文的文献

Disproportionality analysis of post-marketing safety concerns associated with selumetinib in the FDA adverse event reporting system.在FDA不良事件报告系统中对与司美替尼相关的上市后安全问题进行不成比例性分析。

Sci Rep. 2025 Mar 17;15(1):9218. doi: 10.1038/s41598-025-92741-y.

本文引用的文献

Melanoma Res. 2015 Dec;25(6):550-4. doi: 10.1097/CMR.0000000000000186.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验